ONO Pharmaceutical News and Activities

Presence

ONO Pharmaceutical develops and sells medicines for cancer, immune, metabolic, and neurological diseases. Its products and research services support hospitals, clinics, and healthcare professionals in Japan and international markets.

ONO Pharmaceutical products and services overview:

Cancer medicines
Immunology drugs
Metabolic treatments
Neurology medicines
Prescription drugs
Drug discovery

Revenue: ~$3 billion

Employees: 3,900

Headquarters: Osaka, Japan

ONO Pharmaceutical is one of the...

ONO Pharmaceutical is a company listed under the stock ticker 4528 (JP).

ONO Pharmaceutical has a direct presence in 2 countries.

Executives

View the org chart displaying its 61 main executives

Most searched biographies at ONO Pharmaceutical

Popular executive movements at ONO Pharmaceutical

Toshihiro Tsujinaka who was Executive Director, Corporate Strategy & Planning, becomes Representative Director, Senior Executive Officer, Chief Officer of CMC & Production (posted on March 3 2026).
Harumi Nakano who was Senior Director, Corporate Strategy & Planning, Business Management, becomes Corporate Officer, Senior Director, Finance & Accounting Department (posted on March 3 2026).
Masaki Itoh who was Corporate Officer, Division Director, Corporate Strategy & Planning, Business Management Division, Business Management Department and President, Ono Digital health Investment, becomes Corporate Executive Officer, Chief Officer of Finance & Accounting (posted on March 3 2026).

Click here to view some more movements at ONO Pharmaceutical

Create your alert
to follow the executive moves at ONO Pharmaceutical.